{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:50:42Z","timestamp":1791571842588,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ecl.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T15:14:01Z","timestamp":1677424441000},"page":"445-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Lipid Disorders and Metabolic-Associated Fatty Liver Disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Shima Dowla","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.ecl.2023.01.003_bib2","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.ecl.2023.01.003_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.17165","article-title":"Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses","volume":"56","author":"Yi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ecl.2023.01.003_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ecl.2023.01.003_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.003_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ecl.2023.01.003_bib9","unstructured":"Patni N., Ahmad Z., Wilson D.P., Genetics and dyslipidemia, In: Feingold K.R., editor, Endotext. 2000, South; Dartmouth (MA). Bethesda, 1\u201321."},{"issue":"2","key":"10.1016\/j.ecl.2023.01.003_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2019.03.026","article-title":"Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations","volume":"71","author":"Youssefian","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.ecl.2023.01.003_bib11","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ecl.2023.01.003_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11892-021-01377-5","article-title":"Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications","volume":"21","author":"Martin","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of Cholesterol-Associated Steatohepatitis in the Development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.ecl.2023.01.003_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.003_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ecl.2023.01.003_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of Diabetic Dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J\u00a0Atheroscler Thromb"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.003_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.35772\/ghm.2020.01078","article-title":"Secondary dyslipidemia: its treatments and association with atherosclerosis","volume":"3","author":"Yanai","year":"2021","journal-title":"Glob Health Med"},{"issue":"6","key":"10.1016\/j.ecl.2023.01.003_bib19","first-page":"1161","article-title":"Natural History of NAFLD","volume":"10","author":"Pais","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.003_bib20","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.ecl.2023.01.003_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2023.01.003_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2013.06.002","article-title":"Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease","volume":"379","author":"Koliaki","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2023.01.003_bib24","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI34587","article-title":"Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes","volume":"118","author":"Song","year":"2008","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.ecl.2023.01.003_bib25","first-page":"357","article-title":"Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic","volume":"15","author":"Pandyarajan","year":"2019","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.003_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A population-based study on the prevalence of NASH using scores validated against liver histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.ecl.2023.01.003_bib28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.ecl.2023.01.003_bib29","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2023.01.003_bib30","series-title":"Global perspectives on childhood obesity: current status consequences and prevention","first-page":"255","article-title":"Non-alcoholic fatty liver disease in children with obesity","author":"Dowla S","year":"2019"},{"issue":"4","key":"10.1016\/j.ecl.2023.01.003_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"Sahebkar","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.ecl.2023.01.003_bib32","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.003_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"Soderberg","year":"2010","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.ecl.2023.01.003_bib34","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ecl.2023.01.003_bib35","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"21","key":"10.1016\/j.ecl.2023.01.003_bib36","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2023.01.003_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy","volume":"3","author":"Zhang","year":"2015","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"8","key":"10.1016\/j.ecl.2023.01.003_bib39","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/jc.2017-00867","article-title":"Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial","volume":"102","author":"Bril","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2023.01.003_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease","volume":"24","author":"Martin","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"9756","key":"10.1016\/j.ecl.2023.01.003_bib41","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ecl.2023.01.003_bib42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/MCG.0b013e31819c392e","article-title":"A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial","volume":"43","author":"Nelson","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2005.08.021","article-title":"Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients","volume":"184","author":"Antonopoulos","year":"2006","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ecl.2023.01.003_bib44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1185\/030079906X104696","article-title":"Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study","volume":"22","author":"Athyros","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.ecl.2023.01.003_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A\u00a0pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","author":"Fernandez-Miranda","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"17","key":"10.1016\/j.ecl.2023.01.003_bib46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ecl.2023.01.003_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2006.02885.x","article-title":"Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study","volume":"23","author":"Capanni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ecl.2023.01.003_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.ecl.2023.01.003_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2023.01.003_bib50","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852923000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:44Z","timestamp":1760176064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852923000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0889852923000038"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2023.01.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid Disorders and Metabolic-Associated Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}